Troglitazone
Troglitazone is the first of a new group of oral antidiabetic drugs, the       thiazolidinediones, and is indicated for the treatment of patients with type 2       (non-insulin-dependent) diabetes mellitus.
 @SUBJECT$  @PREDICAT$  @OBJECT$ , the       thiazolidinediones, and is indicated for the treatment of patients with type 2       (non-insulin-dependent) diabetes mellitus.